Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor Complications.

Barbe MT, Tonder L, Krack P, Debû B, Schüpbach M, Paschen S, Dembek TA, Kühn AA, Fraix V, Brefel-Courbon C, Wojtecki L, Maltête D, Damier P, Sixel-Döring F, Weiss D, Pinsker M, Witjas T, Thobois S, Schade-Brittinger C, Rau J, Houeto JL, Hartmann A, Timmermann L, Schnitzler A, Stoker V, Vidailhet M, Deuschl G; EARLYSTIM study group.

Mov Disord. 2019 Nov 22. doi: 10.1002/mds.27892. [Epub ahead of print]

PMID:
31755599
2.

Prognostic Counseling for Patients With Idiopathic/Isolated Rapid Eye Movement Sleep Behavior Disorder: Should We Tell Them What's Coming? No.

Sixel-Döring F.

Mov Disord Clin Pract. 2019 Oct 1;6(8):669-671. doi: 10.1002/mdc3.12813. eCollection 2019 Nov. No abstract available.

PMID:
31745476
3.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Aug;65:217-223. doi: 10.1016/j.parkreldis.2019.05.023. Epub 2019 Jun 18.

PMID:
31257096
4.

External validation of a data-driven algorithm for muscular activity identification during sleep.

Cesari M, Christensen JAE, Sorensen HBD, Jennum P, Mollenhauer B, Muntean ML, Trenkwalder C, Sixel-Döring F.

J Sleep Res. 2019 Dec;28(6):e12868. doi: 10.1111/jsr.12868. Epub 2019 May 26.

PMID:
31131530
5.

Need for a consensus on definitions and on research methods in RBD and its prodromal phases.

Stefani A, Iranzo A, Sixel-Döring F, Videnovic A, Santamaria J, Trenkwalder C, Högl B.

Sleep. 2019 May 1;42(5). pii: zsz057. doi: 10.1093/sleep/zsz057. No abstract available.

PMID:
31091537
6.

Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registry.

Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kühn AA, Krauss JK, Sixel-Döring F, von Eckardstein K, Deuschl G, Classen J, Winkler D, Voges J, Galazky I, Oertel W, Ceballos-Baumann AO, Lange M, Gharabaghi A, Weiss DT, Volkmann J, Heuschmann PU.

Parkinsonism Relat Disord. 2019 Mar;60:3-9. doi: 10.1016/j.parkreldis.2019.01.016. Epub 2019 Feb 5.

PMID:
30772278
7.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

8.

Validation of a new data-driven automated algorithm for muscular activity detection in REM sleep behavior disorder.

Cesari M, Christensen JAE, Sixel-Döring F, Trenkwalder C, Mayer G, Oertel WH, Jennum P, Sorensen HBD.

J Neurosci Methods. 2019 Jan 15;312:53-64. doi: 10.1016/j.jneumeth.2018.11.016. Epub 2018 Nov 20.

PMID:
30468824
9.

Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).

Mollenhauer B, Zimmermann J, Sixel-Döring F, Focke NK, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Friede T, Trenkwalder C; DeNoPa Study Group.

Mov Disord. 2019 Jan;34(1):67-77. doi: 10.1002/mds.27492. Epub 2018 Nov 23.

PMID:
30468694
10.

Comparison of computerized methods for rapid eye movement sleep without atonia detection.

Cesari M, Christensen JAE, Kempfner L, Olesen AN, Mayer G, Kesper K, Oertel WH, Sixel-Döring F, Trenkwalder C, Sorensen HBD, Jennum P.

Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy133.

PMID:
30011023
11.

The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease.

Halsband C, Zapf A, Sixel-Döring F, Trenkwalder C, Mollenhauer B.

Mov Disord Clin Pract. 2018 Mar 1;5(2):171-176. doi: 10.1002/mdc3.12591. eCollection 2018 Mar-Apr.

12.

Polysomnographic findings in restless legs syndrome (RLS) patients with severe augmentation.

Steinke SS, Trenkwalder C, Zimmermann J, Sixel-Döring F, Muntean ML.

Sleep Med. 2018 Aug;48:79-85. doi: 10.1016/j.sleep.2018.04.010. Epub 2018 May 5.

PMID:
29860190
13.

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.

Ouled Amar Bencheikh B, Ruskey JA, Arnulf I, Dauvilliers Y, Monaca CC, De Cock VC, Gagnon JF, Spiegelman D, Hu MTM, Högl B, Stefani A, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Mollenhauer B, Sixel-Döring F, Trenkwalder C, Oertel W, Montplaisir JY, Postuma RB, Rouleau GA, Gan-Or Z.

Parkinsonism Relat Disord. 2018 Jul;52:98-101. doi: 10.1016/j.parkreldis.2018.03.019. Epub 2018 Mar 21.

PMID:
29576439
14.

Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy.

Stefani A, Heidbreder A, Brandauer E, Guaita M, Neier LM, Mitterling T, Santamaria J, Iranzo A, Videnovic A, Trenkwalder C, Sixel-Döring F, Wenning GK, Chade A, Poewe W, Gershanik OS, Högl B.

Sleep. 2018 Jun 1;41(6). doi: 10.1093/sleep/zsy053.

15.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
16.

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.

Heintz-Buschart A, Pandey U, Wicke T, Sixel-Döring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P.

Mov Disord. 2018 Jan;33(1):88-98. doi: 10.1002/mds.27105. Epub 2017 Aug 26.

17.

Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort.

Schade S, Sixel-Döring F, Ebentheuer J, Schulz X, Trenkwalder C, Mollenhauer B.

Mov Disord Clin Pract. 2017 Jun 30;4(5):755-762. doi: 10.1002/mdc3.12511. eCollection 2017 Sep-Oct.

18.

Asphyxia due to laryngeal spasm as a severe complication of awake deep brain stimulation for Parkinson's disease: a case report.

von Eckardstein KL, Sixel-Döring F, Kazmaier S, Trenkwalder C, Hoover JM, Rohde V.

BMC Neurol. 2016 Nov 8;16(1):216.

19.

Clinically relevant cut-off values for the Parkinson's Disease Sleep Scale-2 (PDSS-2): a validation study.

Muntean ML, Benes H, Sixel-Döring F, Chaudhuri KR, Suzuki K, Hirata K, Zimmermann J, Trenkwalder C.

Sleep Med. 2016 Aug;24:87-92. doi: 10.1016/j.sleep.2016.06.026. Epub 2016 Aug 24.

PMID:
27810191
20.

The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease.

Sixel-Döring F, Zimmermann J, Wegener A, Mollenhauer B, Trenkwalder C.

Sleep. 2016 Sep 1;39(9):1737-42. doi: 10.5665/sleep.6102.

21.

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

Mollenhauer B, Zimmermann J, Sixel-Döring F, Focke NK, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Trautmann E, Zetterberg H, Taylor P, Friede T, Trenkwalder C; DeNoPa Study Group.

Neurology. 2016 Jul 12;87(2):168-77. doi: 10.1212/WNL.0000000000002651. Epub 2016 May 6.

22.

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.

Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, Henriksen T, Sesar Á, Poewe W; Expert Consensus Group for Use of Apomorphine in Parkinson's Disease, Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Martínez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K.

Parkinsonism Relat Disord. 2015 Sep;21(9):1023-30. doi: 10.1016/j.parkreldis.2015.06.012. Epub 2015 Jun 17. Review.

PMID:
26189414
23.

Serum Ferritin Levels in Parkinson's Disease Patients with and without Restless Legs Syndrome.

Muntean ML, Sixel-Döring F, Trenkwalder C.

Mov Disord Clin Pract. 2015 Jun 4;2(3):249-252. doi: 10.1002/mdc3.12165. eCollection 2015 Sep.

24.

REM sleep-associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations.

Sixel-Döring F, Lohmann K, Klein C, Trenkwalder C, Mollenhauer B.

Mov Disord. 2015 Apr;30(4):597-8. doi: 10.1002/mds.26193. Epub 2015 Mar 15. No abstract available.

PMID:
25771888
25.

REM Sleep Behavioral Events and Dreaming.

Muntean ML, Trenkwalder C, Walters AS, Mollenhauer B, Sixel-Döring F.

J Clin Sleep Med. 2015 Apr 15;11(5):537-41. doi: 10.5664/jcsm.4698.

26.

Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's disease.

Stiasny-Kolster K, Sixel-Döring F, Trenkwalder C, Heinzel-Gutenbrunner M, Seppi K, Poewe W, Högl B, Frauscher B.

Sleep Med. 2015 Jan;16(1):186-9. doi: 10.1016/j.sleep.2014.08.014. Epub 2014 Nov 13.

PMID:
25534709
27.

Restless Legs Syndrome: Psychiatric Comorbidities Are More Important Than Neuroticism.

Trautmann E, Barke A, Frisch JU, Schmidt AL, Kunert F, Canelo M, Sixel-Döring F, Trenkwalder C.

Behav Sleep Med. 2015;13(5):375-86. doi: 10.1080/15402002.2014.919917. Epub 2014 Jun 19.

PMID:
24945565
28.

REM sleep behavior disorder in Parkinson's disease.

Muntean ML, Sixel-Döring F, Trenkwalder C.

J Neural Transm (Vienna). 2014 Mar 22. [Epub ahead of print]

PMID:
24658661
29.

Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease?

Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C.

Sleep. 2014 Mar 1;37(3):431-8. doi: 10.5665/sleep.3468.

30.

[REM sleep behavior disorder as a prodromal stage of α-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy].

Oertel WH, Depboylu C, Krenzer M, Vadasz D, Ries V, Sixel-Döring F, Mayer G.

Nervenarzt. 2014 Jan;85(1):19-25. doi: 10.1007/s00115-013-3891-8. Review. German.

PMID:
24399499
31.

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort.

Mollenhauer B, Trautmann E, Sixel-Döring F, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Focke NK, Kumar KR, Lohmann K, Klein C, Schlossmacher MG, Kohnen R, Friede T, Trenkwalder C; DeNoPa Study Group.

Neurology. 2013 Oct 1;81(14):1226-34. doi: 10.1212/WNL.0b013e3182a6cbd5. Epub 2013 Aug 30.

PMID:
23997153
32.

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.

Schenck CH, Montplaisir JY, Frauscher B, Hogl B, Gagnon JF, Postuma R, Sonka K, Jennum P, Partinen M, Arnulf I, Cochen de Cock V, Dauvilliers Y, Luppi PH, Heidbreder A, Mayer G, Sixel-Döring F, Trenkwalder C, Unger M, Young P, Wing YK, Ferini-Strambi L, Ferri R, Plazzi G, Zucconi M, Inoue Y, Iranzo A, Santamaria J, Bassetti C, Möller JC, Boeve BF, Lai YY, Pavlova M, Saper C, Schmidt P, Siegel JM, Singer C, St Louis E, Videnovic A, Oertel W.

Sleep Med. 2013 Aug;14(8):795-806. doi: 10.1016/j.sleep.2013.02.016. Epub 2013 Jul 22. Erratum in: Sleep Med. 2014 Jan;15(1):157.

PMID:
23886593
33.

[Early recognition of Parkinson's disease. Objectifiable non-motor symptoms and biomarkers].

Mollenhauer B, Sixel-Döring F, Storch A, Schneider C, Hilker R, Kalbe E.

Nervenarzt. 2013 Aug;84(8):918-26. doi: 10.1007/s00115-013-3756-1. Review. German.

PMID:
23831930
34.

No Difference in Sleep and RBD between Different Types of Patients with Multiple System Atrophy: A Pilot Video-Polysomnographical Study.

Muntean ML, Sixel-Döring F, Trenkwalder C.

Sleep Disord. 2013;2013:258390. doi: 10.1155/2013/258390. Epub 2013 Mar 28.

35.

Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects.

Mollenhauer B, Trautmann E, Taylor P, Manninger P, Sixel-Döring F, Ebentheuer J, Trenkwalder C, Schlossmacher MG.

Neurosci Lett. 2013 Jan 4;532:44-8. doi: 10.1016/j.neulet.2012.11.004. Epub 2012 Nov 10.

PMID:
23149132
36.

Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease?

Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C.

Sleep Med. 2012 Oct;13(9):1178-83. doi: 10.1016/j.sleep.2012.06.009. Epub 2012 Jul 28.

PMID:
22841842
37.

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system.

Mollenhauer B, Trautmann E, Otte B, Ng J, Spreer A, Lange P, Sixel-Döring F, Hakimi M, Vonsattel JP, Nussbaum R, Trenkwalder C, Schlossmacher MG.

J Neural Transm (Vienna). 2012 Jul;119(7):739-46. doi: 10.1007/s00702-012-0784-0. Epub 2012 Mar 18.

38.

Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.

Voon V, Schoerling A, Wenzel S, Ekanayake V, Reiff J, Trenkwalder C, Sixel-Döring F.

BMC Neurol. 2011 Sep 28;11:117. doi: 10.1186/1471-2377-11-117.

39.

Associated factors for REM sleep behavior disorder in Parkinson disease.

Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C.

Neurology. 2011 Sep 13;77(11):1048-54. doi: 10.1212/WNL.0b013e31822e560e. Epub 2011 Aug 10.

PMID:
21832215
40.

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.

Sixel-Döring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C.

J Neurol. 2011 Dec;258(12):2147-54. doi: 10.1007/s00415-011-6076-z. Epub 2011 May 6.

PMID:
21547379
41.

Cost-of-illness in multiple system atrophy and progressive supranuclear palsy.

Winter Y, Stamelou M, Cabanel N, Sixel-Döring F, Eggert K, Höglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE.

J Neurol. 2011 Oct;258(10):1827-34. doi: 10.1007/s00415-011-6028-7. Epub 2011 Apr 10.

PMID:
21479850
43.

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.

Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.

Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Erratum in: Lancet Neurol. 2011 Apr;10(4):297.

PMID:
21317042
44.

Parkinson's disease sleep scale--validation of the revised version PDSS-2.

Trenkwalder C, Kohnen R, Högl B, Metta V, Sixel-Döring F, Frauscher B, Hülsmann J, Martinez-Martin P, Chaudhuri KR.

Mov Disord. 2011 Mar;26(4):644-52. doi: 10.1002/mds.23476. Epub 2011 Feb 10.

PMID:
21312275
45.

Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study.

Oertel WH, Benes H, Garcia-Borreguero D, Högl B, Poewe W, Montagna P, Ferini-Strambi L, Sixel-Döring F, Trenkwalder C, Partinen M, Saletu B, Polo O, Fichtner A, Schollmayer E, Kohnen R, Cassel W, Penzel T, Stiasny-Kolster K.

Sleep Med. 2010 Oct;11(9):848-56. doi: 10.1016/j.sleep.2010.02.014. Epub 2010 Sep 1.

PMID:
20813583
46.

[Long-term care after deep brain stimulation of patients with Parkinson's disease].

Sixel-Döring F, Ebersbach G.

Nervenarzt. 2010 Jun;81(6):688-95. doi: 10.1007/s00115-010-2940-9. Review. German.

PMID:
20437025
47.

Rotigotine transdermal delivery for the treatment of restless legs syndrome.

Sixel-Döring F, Trenkwalder C.

Expert Opin Pharmacother. 2010 Mar;11(4):649-56. doi: 10.1517/14656561003621257. Review.

PMID:
20163275
48.

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).

Dodel R, Spottke A, Gerhard A, Reuss A, Reinecker S, Schimke N, Trenkwalder C, Sixel-Döring F, Herting B, Kamm C, Gasser T, Sawires M, Geser F, Köllensperger M, Seppi K, Kloss M, Krause M, Daniels C, Deuschl G, Böttger S, Naumann M, Lipp A, Gruber D, Kupsch A, Du Y, Turkheimer F, Brooks DJ, Klockgether T, Poewe W, Wenning G, Schade-Brittinger C, Oertel WH, Eggert K.

Mov Disord. 2010 Jan 15;25(1):97-107. doi: 10.1002/mds.22732.

PMID:
20014118
49.

Skin complications in deep brain stimulation for Parkinson's disease: frequency, time course, and risk factors.

Sixel-Döring F, Trenkwalder C, Kappus C, Hellwig D.

Acta Neurochir (Wien). 2010 Feb;152(2):195-200. doi: 10.1007/s00701-009-0490-3. Epub 2009 Aug 29.

PMID:
19727546
50.

[Deep brain stimulation for tremor in multiple sclerosis : consensus recommendations of the German Deep Brain Stimulation Association].

Timmermann L, Deuschl G, Fogel W, Hilker R, Kupsch A, Lange M, Schrader C, Sixel-Döring F, Volkmann J, Benecke R; Deep Brain Stimulation Association.

Nervenarzt. 2009 Jun;80(6):673-7. doi: 10.1007/s00115-009-2697-1. German.

PMID:
19471902

Supplemental Content

Loading ...
Support Center